Diabetes mellitus
type 2 group I
Atherosclerosis
group II
Control
group
(A+B) (C+D)
anti- HSP 60/65 [ng/ml] 55.67 ± 65.43 82.98 ± 111.18 26.09 ± 13.85
significance A+B vs. C+D;
NS
A+B vs. contr;
p<0.05
C+D vs. contr;
p<0.01
 
Results are expressed as mean ± standard deviation. NS: Not Statistically Significant
Table 4: The concentration of anti-HSP 60/65 antibody in the serum of patientswith diabetic macrovascular disease and of patients with atherosclerosis without disorders of carbohydrate metabolism.